Close Menu

NIH

From changes in trial enrollment to increased flexibility, clinical trials in precision oncology and other fields are feeling the brunt of the ongoing COVID-19 pandemic.

The authors of the study noted that these genetic findings could guide better clinical decisions for patients and improve outcomes.